“…Numerous hyperpolarized xenon‐129 (HXe) MRI approaches have emerged for assessing lung function, with applications in the diagnosis or characterization of various lung disorders, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and others 1‐12 . Importantly, this modality is capable of directly measuring pulmonary gas exchange by taking advantage of the chemical shifts xenon exhibits when moving from the alveolar air spaces (gas‐phase) into the parenchyma (dissolved‐phase) 13‐19 . However, imaging dissolved‐phase (DP) HXe remains challenging, as only approximately 2% of inhaled xenon dissolves into the lung parenchyma, 20,21 and the of the DP signal at 1.5T is only on the order of 1‐2 ms. As a result, DP imaging techniques based on xenon gas uptake, such as chemical shift imaging (CSI), 22 DP excitation imaging, 16,23 IDEAL 15 or Dixon‐type DP acquisitions, 13,24,25 are frequently limited by low spatial resolution or inefficient radial k‐space sampling schemes.…”